 Home > Medical News > Latest Medical News > China's first new crown oral drug VV116 is expected to apply for listing in the second half of the year

China's first new crown oral drug VV116 is expected to apply for listing in the second half of the year

 Last Update: 2022-03-09
 Source: Internet
 Author: User

Tags

research chemicals reddit

clopidogrel drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

It was learned on January 17 that VV116, the only small molecule drug for the treatment of COVID-19 that has been approved for clinical trials in China, will start its NDA application as soon as it passes the clinical trials within the year
.

Preclinical pharmacodynamic studies have shown that VV116 has significant inhibitory activity against the original and variant strains of the new coronavirus, such as delta virus, in vitro

According to public information, at present, there are three main technical routes for the research and development of new crown treatment drugs: drugs that block the entry of viruses into cells (mostly antibody drugs), drugs that inhibit virus replication (mostly small molecule drugs), and drugs that regulate the human immune system.
(Chinese herbal medicine, etc.
)
.

VV116 is currently the only small molecule drug for the treatment of COVID-19 that has been approved for clinical trials in China (there are already 2 small molecules abroad: Merck's monupavir and Pfizer's paciclovir have been approved for marketing)

VV116 was jointly developed by Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Wuhan Institute of Virology, Chinese Academy of Sciences, Xinjiang Institute of Physical and Chemical Technology, Chinese Academy of Sciences, and Central Asia Drug Research and Development Center, Chinese Academy of Sciences, and was approved for clinical trials on November 2, 2021

Reference source: Financial Associated Press, The Paper

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.